Your browser doesn't support javascript.
loading
Validated spectrophotometric and chromatographic methods for analysis of the recently approved hepatitis C antiviral combination ledipasvir and sofosbuvir.
Baker, M M; El-Kafrawy, D S; Mahrous, M S; Belal, T S.
Affiliation
  • Baker MM; Methodology Department, Pharco Pharmaceuticals Company, Alexandria, Egypt.
  • El-Kafrawy DS; Pharmaceutical Chemistry Department, Faculty of Pharmacy, University of Alexandria, Elmessalah 21521, Alexandria, Egypt.
  • Mahrous MS; Pharmaceutical Chemistry Department, Faculty of Pharmacy, University of Alexandria, Elmessalah 21521, Alexandria, Egypt.
  • Belal TS; Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, University of Alexandria, Elmessalah 21521, Alexandria, Egypt. Electronic address: tbelaleg@yahoo.com.
Ann Pharm Fr ; 76(1): 16-31, 2018 Jan.
Article in En | MEDLINE | ID: mdl-28842163
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Spectrophotometry, Ultraviolet / Benzimidazoles / Hepatitis C / Fluorenes / Sofosbuvir Language: En Journal: Ann Pharm Fr Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Spectrophotometry, Ultraviolet / Benzimidazoles / Hepatitis C / Fluorenes / Sofosbuvir Language: En Journal: Ann Pharm Fr Year: 2018 Document type: Article Affiliation country: Country of publication: